Armistice Capital »

Sofi Technologies shares owned by Armistice Capital

Quarter-by-quarter ownership of Sofi Technologies (SOFI) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Sofi Technologies

Tip: Access up to 7 years of quarterly data

All positions including Sofi Technologies held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sofi Technologies by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $250k 14k 17.93

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Sofi Technologies

Susquehanna International
BlackRock
Vanguard Capital Management
Jane Street
UBS Group
Goldman Sachs Group
Vanguard Portfolio Management
Citadel Advisors
State Street Corporation
D. E. Shaw & Co
Geode Capital Management
Morgan Stanley
Norges Bank Investment Management
Millennium Management
Bank Of Montreal

View all funds holding Sofi Technologies